Wuxi AppTec and Pfizer contributed to a series A round that will support progress of Simcha Therapeutics’ immuno-oncology treatments toward clinical trials.
Month: June 2020
Everbright Photonics lasers in on series C
Up Optotech-backed laser-diode chip foundry Everbright Photonics secured $21.2m in a round led by brokerage Huatai Securities.
Slowdown, what slowdown?
The big news stories of last week highlighted on the Global Venturing Review podcast noted the ongoing flotation bonanza, massive early-stage deals, launches of multi-billion dollar corporate venturing programs and large trade sales.
Zuoyebang hangs up $750m
SoftBank Vision Fund made its first investment in Baidu’s online education spinoff as part of a series E round reportedly set to value it at $6.5bn pre-money.
Oscar hosts Alphabet in $225m round
The health insurance provider pushed its overall funding past $1.5bn in a late-stage round that included long-term investor Alphabet.
Akouos acquires $213m in initial public offering
The hearing loss treatment developer, which counts Novartis Venture Fund and Partners Innovation Fund as investors, floated above its range.
Salesforce takes nine-figure amount to Tanium
The endpoint management software provider has secured roughly $120m from strategic partner Salesforce, bumping its valuation up from $6.5bn to $9bn.
Fusion Pharma fetches $213m in IPO
Johnson & Johnson and Varian Medical exited the cancer radiotherapy developer in an upsized initial public offering after $158m in funding.
Poseida slots in $110m ahead of IPO
Novartis and Transposagen-backed gene and cell therapy developer Poseida Therapeutics closed the series D round two days after filing to go public.
YJ Capital wangles new COO
Hogil Doh has ascended to a chief operating officer position at Yahoo Japan’s investment arm, after joining in February from fellow corporate venturing unit Rakuten Ventures.
Enterome enters series E stage
Nestlé Health Science and Takeda participated in a series E round for Enterome, which received $52.6m in equity and debt financing through the deal.
Artiva arrives with $78m
Artiva Biotherapeutics is leveraging GC LabCell’s cell therapy technology to target cancer, and has raised series A funding from backers including the latter.
Analysis: Mastercard buys Finicity for $825m
Mastercard will buy financial data technology provider Finicity in a deal that could reach $985m, giving Experian an exit. This is yet another large exits in this space this year after the acquisitions of Plaid and Credit Karma earlier.
Monstar Lab experiments with Skylight partnership
The corporates are extending a partnership that stretches back to their investment in recruitment startup TalentEx two years ago.